Table 2 Concentration (ng/g) of plasma neurometabolites in cohort 1
Metabolites | Platform | Metabolic pathway | MDD | HC | Log2(FC) | p-value |
|---|---|---|---|---|---|---|
SA | GC-MS | GABAergic | 922.40±37.34 | 1083.14±48.10 | −0.23 | 0.01 |
GABA | GC-MS | GABAergic | 373.45±2.50 | 335.89±3.18 | 0.15 | 0.000 |
α-KG | GC-MS | GABAergic | 10253.24±460.18 | 12863.54±897.06 | −0.33 | 0.012 |
Gln | GC-MS | GABAergic | 33032.90±2249.47 | 51223.80±2949.99 | −0.63 | 0.000 |
Glu | GC-MS | GABAergic | 15246.52±1107.83 | 14274.68±1024.47 | 0.10 | 0.521 |
Orn | GC-MS | GABAergic | 15908.58±824.00 | 14520.46±801.36 | 0.13 | 0.23 |
l-Tyr | GC-MS | Catecholaminergic | 8755.64±379.78 | 10224.73±527.16 | −0.22 | 0.026 |
Tyra | LC-MS/MS | Catecholaminergic | 19.26±4.30 | 1.98±0.33 | 3.28 | 0.000 |
DOPN | LC-MS/MS | Catecholaminergic | 1.01±0.16 | 0.28±0.04 | 1.86 | 0.000 |
L-DOPA | GC-MS | Catecholaminergic | 153.67±3.75 | 145.16±3.28 | 0.08 | 0.091 |
l-Phe | GC-MS | Catecholaminergic | 10508.21±355.70 | 9671.28±538.41 | 0.12 | 0.198 |
HA | LC-MS/MS | Catecholaminergic | 56.11±4.13 | 52.85±3.50 | 0.09 | 0.549 |
Trp | GC-MS | Serotonergic | 591.01±45.51 | 902.68±89.38 | −0.61 | 0.002 |
Kyn | LC-MS/MS | Serotonergic | 1571.31±116.29 | 1992.25±78.81 | −0.34 | 0.004 |
3-HA | GC-MS | Serotonergic | 819.20±30.63 | 802.80±38.78 | 0.03 | 0.741 |
5-HT | LC-MS/MS | Serotonergic | 140.27±28.80 | 186.63±79.81 | −0.41 | 0.586 |
5-HIAA | LC-MS/MS | Serotonergic | 21.30±2.03 | 18.31±1.17 | 0.22 | 0.206 |
NAS | LC-MS/MS | Serotonergic | 0.77±0.11 | 0.85±0.11 | −0.15 | 0.593 |
Tra | LC-MS/MS | Serotonergic | 1.64±0.22 | 1.44±0.11 | 0.19 | 0.430 |